NPI: 1568547032 · SCHUYLER, NE 68661 · Ambulatory Surgical Clinic/Center · NPI assigned 10/25/2006
Authorized official KUIPER, EVERT controls 20+ related entities in our dataset. Read more
| Authorized Official | KUIPER, EVERT (CEO - CHI HEALTH) |
| NPI Enumeration Date | 10/25/2006 |
Other providers sharing the same authorized official: KUIPER, EVERT
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 1,684 | $133K |
| 2019 | 1,377 | $123K |
| 2020 | 1,221 | $74K |
| 2021 | 2,806 | $192K |
| 2022 | 2,482 | $221K |
| 2023 | 626 | $55K |
| 2024 | 169 | $26K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 1,711 | 1,483 | $392K |
| 99284 | Emergency department visit for the evaluation and management, high severity | 297 | 274 | $107K |
| 80053 | Comprehensive metabolic panel | 1,242 | 1,058 | $71K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1,806 | 1,545 | $67K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 997 | 492 | $40K |
| 80050 | General health panel | 200 | 179 | $28K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 683 | 660 | $22K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 254 | 241 | $18K |
| 36415 | Collection of venous blood by venipuncture | 980 | 775 | $17K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 58 | 56 | $10K |
| J3490 | Unclassified drugs | 1,085 | 456 | $9K |
| 71046 | Radiologic examination, chest; 2 views | 59 | 55 | $7K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 14 | 12 | $5K |
| 80048 | Basic metabolic panel (calcium, ionized) | 130 | 109 | $5K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 46 | 38 | $4K |
| 84443 | Thyroid stimulating hormone (TSH) | 91 | 89 | $3K |
| 81001 | 93 | 79 | $3K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 183 | 175 | $3K |
| J7030 | Infusion, normal saline solution , 1000 cc | 32 | 24 | $3K |
| 86140 | 71 | 65 | $2K | |
| 81003 | 176 | 161 | $2K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 30 | 25 | $1K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 18 | 15 | $1K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 27 | 25 | $1K |
| 87081 | 12 | 12 | $767.82 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 50 | 49 | $718.01 |
| 87807 | 20 | 20 | $482.40 |